What Arthrex Australia does

Arthrex Australia Pty Ltd is the Australian and New Zealand operating subsidiary of Arthrex, Inc., a privately held U.S. medical device company founded in 1981 and headquartered in Naples, Florida. The subsidiary, headquartered in Frenchs Forest (Sydney) with a New Zealand office in Parnell (Auckland), has served the ANZ market for more than 20 years and transitioned to a direct representation model across all major capital cities in 2021, replacing its prior distributor network. Its portfolio centers on minimally invasive orthopedic surgery and sports medicine, spanning arthroscopy systems, shoulder arthroplasty (including CT-based VIPT planning software), trauma implants and instruments, distal extremities products, orthobiologics (PRP systems and regenerative therapies), the Synergy 3-in-1 imaging console, the Synergy Surgeon App, and the Arthrex Vet Systems veterinary line.

Underlying technology combines rigid optical-fiber arthroscopes with high-resolution camera visualization and miniaturized instruments for joint repair, integrated with a single-console imaging platform (Synergy) and tablet-based intraoperative documentation. Manufacturing is conducted in-house under strict quality assurance, and Arthrex develops over 1,000 new products and procedures annually. The business model is hardware-based medical device sales to orthopedic surgeons, sports medicine physicians, trauma surgeons, shoulder arthroplasty surgeons, and veterinary surgeons, executed through direct enterprise field sales and a global network of in-OR Technology Consultants; pricing is quote-based at the institutional level and not publicly disclosed.

Go-to-market combines direct enterprise sales with a Medical Education engine that trains thousands of healthcare professionals annually through ArthroLab hands-on facilities and virtual programs, alongside the OrthoPedia patient education platform and a surgeon-facing mobile app. The company remains privately held under a family-business ownership structure, has no external institutional investors, and operates under APAC regional oversight from Singapore alongside direct operations in China, Japan, and South Korea and distributor partners across ASEAN.

Name

Arthrex Australia

Legal name

Arthrex Australia Pty Ltd

Website

https://arthrex.com.au

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

Arthrex Australia Pty Ltd is the ANZ direct subsidiary of privately held U.S. medical device leader Arthrex, Inc., selling minimally invasive orthopedic implants, arthroscopy systems, shoulder arthroplasty, orthobiologics, and imaging consoles to orthopedic surgeons and hospitals in Australia and New Zealand.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics) (HLAMAFAE), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Orthopedic medical devices
• Arthroscopy surgical instruments
• Sports medicine implants
• Shoulder arthroplasty systems
• Orthobiologics products

Headquarters

HQ city

Frenchs Forest

HQ country

Australia

HQ region

Oceania

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of surgical implants, instruments, and medical devices to orthopedic surgeons and healthcare facilities. Products include arthroscopy equipment, trauma implants, shoulder arthroplasty systems, orthobiologics, and veterinary surgical products.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Arthrex Australia Pty Ltd develops, manufactures, and sells orthopedic medical devices for minimally invasive surgery, including arthroscopy systems, shoulder arthroplasty implants with CT-based VIPT planning software, trauma and distal extremities implants, orthobiologics products, and the Synergy imaging platform. The portfolio is sold directly to hospitals and orthopedic surgeons in Australia and New Zealand, supported by in-OR Technology Consultants and a Surgeon App, with a parallel veterinary line for dogs, cats and horses.

Product overview

Arthrex is a global medical device company and leader in sports medicine and less invasive orthopedic surgery. The company develops over 1,000 innovative products and procedures annually. Their portfolio centers on the Shoulder Arthroplasty Suite (anatomic and reverse total shoulder replacements with VIPT planning software), the Synergy System (3-in-1 imaging management console with Synergy Surgeon App for intraoperative documentation), Sports Medicine and Arthroscopy products, Trauma and Distal Extremities implants, and Orthobiologics (PRP systems and regenerative cell therapies). Arthrex Vet Systems extends the portfolio to veterinary care for dogs, cats, and horses.

Differentiator

Problem solved

Functional benefit

Brands

• Arthrex Vet Systems: A division dedicated to Helping Veterinarians Treat Their Patients Better™. Develops hundreds of products specifically designed to improve treatment and care for dogs, cats and horses.
• Arthrex ArthroLab
• Synergy System
• Synergy Surgeon App
• VIP Planning Software
• OrthoPedia

Products and services

• Shoulder Arthroplasty Suite A comprehensive suite of anatomic and reverse total shoulder replacement implants with CT-based VIPT planning software for treating osteoarthritis, post-traumatic arthritis, rotator cuff arthropathy, and fracture management, sold to orthopedic surgeons and hospitals.
• Synergy Imaging System A 3-in-1 console imaging management camera system for operating rooms, incorporating LED light source, image management system, and touch pad-controlled video processor, sold to hospitals and surgical centers.
• Synergy Surgeon App A tablet application enabling surgeons to manage intraoperative photos and videos, review and annotate images, edit video sequences, and generate instant reports for patients or colleagues.
• Orthobiologics Products Biological products including Platelet Rich Plasma (PRP) systems, matrix support materials, and regenerative cell therapies for bone, cartilage, tendon, and ligament tissue repair, sold to sports medicine physicians and orthopedic surgeons.
• Trauma Implants and Instruments Comprehensive range of trauma implants including plates, screws, sutures, and orthobiological products for treating fractures, acute ligament ruptures, and musculotendinous injuries, sold to trauma surgeons and hospitals.
• Sports Medicine and Arthroscopy Products Minimally invasive arthroscopic surgical instruments and implants for joint repair including ligaments, menisci, cartilage, and bone procedures, sold to orthopedic sports medicine surgeons and hospitals.
• Distal Extremities Products Specialized implants and instruments for foot, ankle, hand, and wrist surgery including small joint repairs, ligament reconstruction, and bone surgery, sold to orthopedic and podiatric surgeons.
• Arthrex Vet Systems Veterinary product division offering hundreds of products for dogs, cats, and horses including cartilage repair, ligament stabilization, and orthobiological treatments, sold to veterinary surgeons and animal hospitals.

Quantifiable outcome

• Accelerated tissue regeneration through orthobiologic treatments
• +1 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Stryker: Stryker is a large diversified medical device company with a major sports medicine, arthroscopy and orthopedic implant franchise that directly competes with Arthrex across arthroscopy instruments, shoulder, knee and trauma. Its Mako robotics and integrated OR roadmap parallels Arthrex's Synergy and VIP planning strategy.
• Medtronic: Medtronic is one of the largest medical device companies globally with a spine, surgical, and navigation portfolio that competes with Arthrex in surgical navigation, planning software and trauma/spine. Its scale and digital ecosystem make it a broader competitive reference.
• Zimmer Biomet: Zimmer Biomet is a top-tier orthopedic implants and reconstruction company competing with Arthrex in shoulder arthroplasty, trauma, and joint reconstruction. Its broader portfolio and hospital contracts position it as a direct competitor across Arthrex's implant-heavy product lines.
• Johnson & Johnson MedTech (DePuy Synthes): DePuy Synthes is J&J's orthopedic franchise, competing across joint reconstruction, sports medicine, trauma and extremities with global scale and bundled hospital contracts. It overlaps directly with Arthrex in shoulder, trauma and arthroscopy.

Emerging players

• Bioventus: Bioventus is an orthobiologics company offering regenerative solutions including PRP systems and bone graft substitutes that compete with Arthrex's orthobiologics products. It is a focused peer in the regenerative sports medicine segment.
• Anika Therapeutics: Anika Therapeutics is a focused orthobiologics and hyaluronic-acid based regenerative company. Its regenerative and viscosupplementation portfolio directly overlaps with Arthrex's orthobiologics (PRP, regenerative cells, matrix support) franchise.
• Orthofix Medical: Orthofix is a smaller orthopedic device company focused on spine, trauma and biologics, with extremities and biologic products overlapping Arthrex's trauma and orthobiologics lines. It is a more specialized comparable in select segments.

Direct peers

• Enovis (DJO): Enovis, through its DJO and surgical solutions businesses, provides orthopedic implants, sports medicine devices and rehabilitation products that directly overlap with Arthrex's shoulder, extremities and trauma ranges. It is a meaningful orthopedic and sports medicine peer.
• Smith+Nephew: Smith+Nephew operates a sports medicine and arthroscopy business that directly competes with Arthrex in shoulder repair, knee arthroscopy and orthobiologics. Its portfolio overlap in minimally invasive orthopedic instruments and implants makes it the closest pure-play comparable.
• Conmed Corporation: Conmed is a dedicated surgical and sports medicine device company offering arthroscopy instruments, resection, and orthopedic products that compete head-to-head with Arthrex's arthroscopy core. Its narrower but focused portfolio makes it a close comparable.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arthrex

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arthrex Australia